OncoCyte Announces the Closing of a $10 Million Private Placement of Common Stock
28 mars 2018 20h40 HE
|
OncoCyte Corporation
ALAMEDA, Calif., March 28, 2018 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE American:OCX), a developer of novel, non-invasive liquid biopsy diagnostic tests for the early detection of...
OncoCyte Announces Initial Results of DetermaVu™ Feasibility on New Platforms; Enhancements May Increase Lung Cancer Diagnostic Test’s Clinical Performance
08 mars 2018 16h10 HE
|
OncoCyte Corporation
ALAMEDA, Calif., March 08, 2018 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE American:OCX), a developer of novel, non-invasive liquid biopsy tests for the early detection of cancer, today provided...
OncoCyte Presents Positive Data from its Liquid Biopsy Breast Cancer Diagnostic Test at the San Antonio Breast Cancer Symposium
07 déc. 2017 08h30 HE
|
OncoCyte Corporation
ALAMEDA, Calif., Dec. 07, 2017 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE American:OCX), a developer of novel, non-invasive liquid biopsy tests for the early detection of cancer, today presented...
OncoCyte to Present Data from its Liquid Biopsy Breast Cancer Diagnostic Test at the San Antonio Breast Cancer Symposium
01 déc. 2017 07h00 HE
|
OncoCyte Corporation
ALAMEDA, Calif., Dec. 01, 2017 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE American:OCX), a developer of novel, non-invasive liquid biopsy tests for the early detection of cancer, will present...
OncoCyte Initiates Search for New Independent Director
29 nov. 2017 16h10 HE
|
OncoCyte Corporation
ALAMEDA, Calif., Nov. 29, 2017 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE American:OCX), a developer of novel, non-invasive tests for the early detection of cancer, today announced that it has...
OncoCyte Corporation to Participate in the Benchmark Company, LLC Micro Cap Discovery One-on-One Conference
27 nov. 2017 07h00 HE
|
OncoCyte Corporation
ALAMEDA, Calif., Nov. 27, 2017 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE American:OCX), a developer of novel, non-invasive blood based tests for the early detection of cancer, announced today...
Seasoned Financial Executive Joins OncoCyte as Chief Financial Officer
15 nov. 2017 16h10 HE
|
OncoCyte Corporation
ALAMEDA, Calif., Nov. 15, 2017 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE American:OCX), a developer of novel, non-invasive tests for the early detection of cancer, today announced that Mitch...
OncoCyte Reports Third Quarter 2017 Financial Results
14 nov. 2017 16h10 HE
|
OncoCyte Corporation
ALAMEDA, Calif., Nov. 14, 2017 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE American:OCX), a developer of novel, non-invasive tests for the early detection of cancer, today reported financial...
OncoCyte to Report Third Quarter 2017 Financial Results on November 14, 2017
06 nov. 2017 07h00 HE
|
OncoCyte Corporation
ALAMEDA, Calif., Nov. 06, 2017 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE American:OCX), a developer of novel, non-invasive blood based tests for the early detection of cancer, announced today...
OncoCyte Announces Successful Completion of CLIA Lab Validation Study of its DetermaVu™ Lung Cancer Diagnostic Test; Clinical Validation Study Initiated
27 sept. 2017 07h00 HE
|
OncoCyte Corporation
ALAMEDA, Calif., Sept. 27, 2017 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE American:OCX), a developer of novel, non-invasive, blood-based liquid biopsy tests to assist in the early detection of...